Minimally invasive Ivor Lewis esophagectomy for esophageal cancer.

J Vis Surg

Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Published: November 2016

AI Article Synopsis

Article Abstract

Esophageal cancer is the malignant tumor arising from the esophagus and has a poor prognosis. Squamous cell carcinoma and adenocarcinoma are the main subtypes of esophageal cancer with different risk factors. In the early stage, surgical resection is the most curative treatment modality. However, the procedure is considered an advanced and technically demanding surgery because esophageal cancer surgery includes esophagectomy, lymph node dissection, and a creation of esophageal conduit. Stomach is the commonest organ for the esophageal substitute. In open procedures, pulmonary complications and anastomotic failure are the most severe problems. Minimally invasive esophagectomy (MIE) has been introduced to decrease the postoperative pulmonary complications, but anastomotic failure remains a serious issue because of the extra-anatomical anastomosis between the esophagus and the conduit in the thorax or the neck.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637880PMC
http://dx.doi.org/10.21037/jovs.2016.10.03DOI Listing

Publication Analysis

Top Keywords

esophageal cancer
16
minimally invasive
8
pulmonary complications
8
complications anastomotic
8
anastomotic failure
8
esophageal
6
invasive ivor
4
ivor lewis
4
lewis esophagectomy
4
esophagectomy esophageal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!